8 JULY - FDA will soon publish a Federal Register notice extending the period for public comment on how the agency's regulation of commercial speech can best safeguard public health while complying with First Amendment protections.
FDA will soon publish aFederal Register notice extending the period for public commenton how the agency's regulation of commercial speech can bestsafeguard public health while complying with First Amendmentprotections.http://www.fda.gov/bbs/topics/NEWS/2002/NEW00819.html
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Article
COMMENT PERIOD EXTENDED FOR PUBLIC DISCUSSION OF FDA AND 1ST AMENDMENT
Author(s):
8 JULY - FDA will soon publish a Federal Register notice extending the period for public comment on how the agency's regulation of commercial speech can best safeguard public health while complying with First Amendment protections.
FDA will soon publish aFederal Register notice extending the period for public commenton how the agency's regulation of commercial speech can bestsafeguard public health while complying with First Amendmentprotections.http://www.fda.gov/bbs/topics/NEWS/2002/NEW00819.html
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
New Year, Same Challenges: Pharma’s Ongoing Struggle with FDA 483s
The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game
FDA Approves Moderna’s Updated COVID-19 Vaccines Targeting LP.8.1 Variant
Mastering Antibody-Drug Conjugates
Zemcelpro Stem Cell Therapy Granted EC Conditional Marketing Authorization
Continued Process Verification Is Critical in Pharmaceutical Manufacturing
New Year, Same Challenges: Pharma’s Ongoing Struggle with FDA 483s
The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game
FDA Approves Moderna’s Updated COVID-19 Vaccines Targeting LP.8.1 Variant
Mastering Antibody-Drug Conjugates
Zemcelpro Stem Cell Therapy Granted EC Conditional Marketing Authorization
Continued Process Verification Is Critical in Pharmaceutical Manufacturing